Meteorin-like is associated with poor outcome in invasive candidiasis in mouse models and in humans.

Invasive candidiasis is a leading cause of nosocomial bloodstream infection associated with high mortality, and there is a pressing need to develop biomarker-guided antifungal therapy to improve clinical outcomes. Meteorin-like (METRNL) is a cytokine…

Preview only. Read the full abstract at the source